1/20/2021 4:08:02 PM
Illumina Wins Patent Infringement Suit Against BGI In UK
1/5/2021 7:47:29 PM
Illumina And Helix Collaborate To Assess Prevalence Of New SARS-CoV-2 UK Variant In US
11/12/2020 4:10:32 PM
Illumina Announces Commercial Availability Of The P3 High-output Flow Cell
10/29/2020 5:30:38 PM
Illumina Q3 EPS $1.21 Vs. $1.58 Year Ago
9/21/2020 9:27:52 AM
Illumina To Acquire GRAIL For Cash And Stock Consideration Of $8 Bln
8/6/2020 5:05:50 PM
Illumina Q2 GAAP EPS $0.32 Vs $1.99 Last Year
6/23/2020 2:05:07 AM
Illumina Selects Seven Early-stage Companies To Join The First Global Cohort Of Illumina Accelerator
6/17/2020 7:41:57 PM
Illumina Acquires BlueBee
6/9/2020 10:43:10 PM
Illumina Gets FDA Emergency Use Authorization For Sequencing-Based COVID-19 Diagnostic Test
5/28/2020 6:05:09 AM
Ginkgo Bioworks Announces $70 Mln Investment From Illumina And Existing Investors, General Atlantic And Viking Global
5/18/2020 9:06:00 AM
Natera, Illumina Settle Patent Infringement Action
5/4/2020 4:32:37 PM
Illumina Appoints Alex Aravanis As Chief Technology Officer